cCD79a expression in a case of plasma cell leukemia

Leuk Res. 1998 Jul;22(7):649-53. doi: 10.1016/s0145-2126(98)00009-5.

Abstract

In the present report we analyzed the immunophenotype of the neoplastic cells in a case of primary plasma cell leukemia (PCL). We performed simultaneous analysis of bone marrow and peripheral blood samples to investigate minor phenotypic variations that could explain the tendency of a population to leave medullary compartments. No major differences were observed between the two populations. The phenotype of the malignant clone was: CD38+, CD138+, CD19-, CD56+, CD117-, CD33+, CD44 , CD49e , cCD79a+ with positive cytoplasmic stain for kappa and IgG. Our findings expands the potential uses of cCD79a to cases of PCL with atypical morphology.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antigens, CD / analysis
  • Antigens, CD / biosynthesis*
  • CD79 Antigens
  • Cytoplasm / immunology
  • Female
  • Flow Cytometry
  • Humans
  • Immunophenotyping
  • Leukemia, Plasma Cell / immunology
  • Leukemia, Plasma Cell / metabolism*
  • Plasma Cells / immunology
  • Receptors, Antigen, B-Cell / analysis
  • Receptors, Antigen, B-Cell / biosynthesis*

Substances

  • Antigens, CD
  • CD79 Antigens
  • CD79A protein, human
  • Receptors, Antigen, B-Cell